미국의 급성기 의료 시술용 체어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

U.S. Acute Care Procedure Chair Market Summary

The U.S. acute care procedure chair market size was estimated at USD 103.19 million in 2025 and is projected to reach USD 182.38 million by 2033, growing at a CAGR of 7.37% from 2026 to 2033. This growth can be attributed to the rising volume of outpatient and emergency procedures, increasing demand for workflow-efficient patient handling solutions, expanding adoption of ergonomically advanced chairs in ambulatory surgery centers and hospital emergency departments, and growing emphasis on infection-control-compliant, multifunctional equipment that supports rapid patient turnover and improved clinical outcomes.

Rising hospitalization rates in the U.S. are driving up demand for acute care procedure chairs. The growing burden of diseases, surgical interventions, and age-related health conditions has led to more patients requiring inpatient care. As hospitals experience higher patient volumes, the need for efficient, adaptable, and comfortable procedure chairs increases to support examinations, treatments, and routine clinical workflows. This trend is expected to strengthen market growth in the years to come.

In recent years, the country has experienced growth in admissions to community hospitals and other healthcare facilities.

Thus, the rise in hospital admissions across the U.S. increases the number of patients requiring examinations, treatments, and short-term care, as a result strengthening the demand for acute care procedure chairs and supporting market growth as healthcare facilities manage higher patient volumes.

Moreover, the rising burden of road accidents and sports injuries is expected to drive growth in the U.S. acute care procedure chair industry. These incidents often require surgical procedures, increasing demand for multifunctional treatment and stretcher chairs. According to the National Safety Council, approximately 46,027 individuals died in motor vehicle crashes in the U.S. in 2022 and medically consulted injuries from such incidents totaled 5.2 million that year.

U.S. Acute Care Procedure Chair Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. acute care procedure chair market report based on product, application, and end use:

• U.S. Acute Care Procedure Chair Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Powered Chairs
  • Manual Chairs
• U.S. Acute Care Procedure Chair Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Multi-functional Treatment Chairs
  • Stretcher Chairs
  • General Procedure Chairs
  • Ophthalmic Chairs
  • Gynecological Chairs
  • ENT Chairs
  • Plastic Surgeries
• U.S. Acute Care Procedure Chair End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Acute Care Hospitals
  • In-office Settings
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Emergency Departments

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Acute Care Procedure Chair Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing hospitalization rate
    • 3.2.1.2. Growing burden of road accidents and sports injuries
    • 3.2.1.3. Rising number of plastic surgeries
  • 3.2.2. Market Restraint Impact Analysis
    • 3.2.2.1. Product recalls
  • 3.2.3. Market Opportunity Impact Analysis
    • 3.2.3.1. Strategic partnerships and production facility expansions
    • 3.2.3.2. Expansion of healthcare facilities
    • 3.2.3.3. Advancements in procedure chairs
    • 3.2.3.4. Growing shift to outpatient settings
  • 3.2.4. Market Challenge Impact Analysis
    • 3.2.4.1. Shortage of healthcare professionals
• 3.3. U.S. Acute Care Procedure Chair Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Reimbursement Scenario

Chapter 4. U.S. Acute Care Procedure Chair Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2025 & 2033
• 4.2. Segment Dashboard
• 4.3. U.S. Acute Care Procedure Chair Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.4.1. Powered Chairs
    • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.4.2. Manual Chairs
    • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Acute Care Procedure Chair Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2025 & 2033
• 5.2. Segment Dashboard
• 5.3. U.S. Acute Care Procedure Chair Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.4.1. Home Healthcare
    • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Multi-functional Treatment Chairs
    • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Stretcher Chairs
    • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. General Procedure Chairs
    • 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Ophthalmic Chairs
    • 5.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.6. Gynecological Chairs
    • 5.4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.7. ENT Chairs
    • 5.4.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.8. Plastic Surgeries
    • 5.4.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Acute Care Procedure Chair Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2025 & 2033
• 6.2. Segment Dashboard
• 6.3. U.S. Acute Care Procedure Chair Market by End Use Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.4.1. Acute Care Hospitals
    • 6.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.4.2. In-office Settings
    • 6.4.2.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.4.3. Ambulatory Surgical Centers
    • 6.4.3.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.4.4. Diagnostic Centers
    • 6.4.4.1. Market estimates and forecasts 2021 to 2033 (USD million)
  • 6.4.5. Emergency Departments
    • 6.4.5.1. Market estimates and forecasts 2021 to 2033 (USD million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2025
• 7.4. Company Profiles
  • 7.4.1. Stryker
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Champion Manufacturing Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Midmark Corporation
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. MTI Medical Technology Industries, Inc.
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Zimed Healthcare LLC
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. United Metal Fabricators, Inc. (UMF Medical)
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Infinium Medical (Lemi MD Brusaferri & C. srl)
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. GF Health Products, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Wy'East Medical
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Hill Laboratories Company
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. IOA Healthcare Furniture
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Digiterm Ltd.
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives